TNF-alpha inhibitors have an important role in the treatment of chronic systemic immune-mediated conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and inflammatory bowel diseases. This evidence concerns the gene TNF and ankylosing spondylitis.